Generics make up 90% of prescriptions but only 25% of drug spending - yet they drive 96% of pharmacy profits. Learn how PBMs, consolidation, and spread pricing are squeezing independent pharmacies - and what they're doing to survive.
Read more
Learn how to check for drug interactions before starting new medications with practical steps that prevent dangerous side effects, hospitalizations, and even death. Includes top tools, high-risk combos, and what to ask your doctor.
Read more
Learn how caregivers can prevent dangerous medication errors at home with simple, proven steps - from keeping a full medication list to using pill organizers and talking to pharmacists.
Read more
The FDA uses dissolution testing to ensure generic drugs release medicine at the same rate as brand-name versions, replacing human trials with reliable lab tests. This process guarantees safety, effectiveness, and affordability.
Read more
Remote microphone systems help people with hearing loss understand speech in noisy places like restaurants and meetings. They send clear audio directly to hearing aids, boosting understanding by up to 61% compared to hearing aids alone.
Read more
Rifampin drastically reduces levels of anticoagulants and antivirals by activating liver enzymes that break them down. This can lead to dangerous treatment failures. Learn how to manage this life-threatening interaction.
Read more
Learn how to recognize, treat, and prevent low blood sugar-especially if you have diabetes. Know the signs, what to do fast, and how technology can help you stay safe.
Read more
Discover the major legal and regulatory changes coming in 2025-2026, from California’s labor reforms to federal tax shifts and Supreme Court rulings that will impact businesses, employers, and individuals.
Read more
Learn how to check your name and medication on a prescription label to prevent dangerous errors. Simple steps can stop 67% of preventable mistakes - and save your life.
Read more
Combination NTI drugs offer powerful treatment for complex conditions but face major barriers to generic availability. With no approved fixed-dose combinations in the U.S., patients face higher costs, increased monitoring, and greater risk of adverse events after generic switches.
Read more